INTENSITY THERAPEUTICS, INC. (INTS): Nasdaq/NYSE listing notice — Intensity Therapeutics receives Nasdaq non-compliance notice after director resigns from audit committee

INTENSITY THERAPEUTICS, INC.

Daniel Donovan resigned from audit committee on April 12, 2024, leaving only 2 members; company received Nasdaq deficiency letter on April 18, 2024.
Cure period runs until earlier of next annual stockholder meeting or April 14, 2025; if annual meeting before Oct 9, 2024, then cure expires Oct 9, 2024.
Company intends to appoint a new independent director to the board to serve on the audit committee within the cure period.
Failure to regain compliance could result in delisting; company may appeal any delisting determination to a hearings panel.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INTENSITY THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4), 5605(a)(2), 10A-3).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(c)(4), 5605(a)(2), 10A-3

Exact text from the filing

April 18, 2024, the Company received a letter (the "Letter") from Nasdaq notifying the Company that, as a result of the resignation of Daniel Donovan from the Audit Committee, the Company is not in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605. The Letter further provides that, pursuant to Nasdaq Listing Rule 5605(c)(4), the Company is entitled to a cure period to regain compliance with Nasdaq Listing Rule 5605, which cure period will expire the earlier of the Company's next annual stockholders' meeting or April 14, 2025; or if the n

View on SEC.gov

99 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

INTENSITY THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001567264-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.